Print Page  Close Window

Investor Relations

Overview

MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

Read More

Recent Press Releases

Upcoming Events